Skip to main content
Clinical Trials/NCT01327677
NCT01327677
Completed
Phase 4

Post Craniotomy Analgesia Safety Monitoring With ET CO2

Johns Hopkins University1 site in 1 country137 target enrollmentMay 2011
ConditionsPain
InterventionsFentanyl

Overview

Phase
Phase 4
Intervention
Fentanyl
Conditions
Pain
Sponsor
Johns Hopkins University
Enrollment
137
Locations
1
Primary Endpoint
Respiratory Depression
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This research is being done to compare two methods of giving fentanyl, a narcotic often given to patients following brain surgery and determine if one method has more side effects than the other. Both of these methods are available in the postoperative treatment of pain. This research also is being done to determine if patients receiving narcotic pain medicine will benefit from additional monitoring of carbon dioxide levels. Since narcotic pain medicines can slow down breathing, The investigators want to see if measuring exhaled carbon dioxide levels will help identify a slower breathing rate and improve safety.

Detailed Description

See brief summary

Registry
clinicaltrials.gov
Start Date
May 2011
End Date
May 2014
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult male and female, English speaking patients undergoing supratentorial craniotomy for tumor under general anesthesia at the Johns Hopkins Hospital will be eligible for this study.

Exclusion Criteria

  • pregnant women
  • patients with post operative neurological changes
  • patients who remain intubated post-operatively
  • patients who require the use of concomitant administration of sedatives
  • patients who are unable to initiate a PCA bolus
  • patients who are unable to communicate verbally
  • patients who are allergic to fentanyl
  • patients who have a history of narcotic abuse
  • patients who have a history of chronic pain requiring opioids
  • patients who have been in any investigational drug trial within 1 month of the treatment day

Arms & Interventions

Pro re nata (PRN) fentanyl

A nurse can give the patient up to 3 doses of fentanyl intravenously (through a vein) each hour whenever a patient indicates that he or she is in pain.

Intervention: Fentanyl

Intravenous Patient-controlled Analgesia (IVPCA) fentanyl

Fentanyl will be given with a Patient Controlled Analgesia (PCA) pump.

Intervention: Fentanyl

Outcomes

Primary Outcomes

Respiratory Depression

Time Frame: Up to 24 hours postoperatively.

Defined by maximal End Tidal CO2 (mmHg)

Secondary Outcomes

  • Hypoxia(up to 24 hours postoperatively)

Study Sites (1)

Loading locations...

Similar Trials